103 related articles for article (PubMed ID: 34167590)
1. Adherence to oral amoxicillin dispersible tablets in children with community-acquired pneumonia enrolled in clinical trials in Malawi.
Ginsburg AS; May S
Pneumonia (Nathan); 2021 Jun; 13(1):10. PubMed ID: 34167590
[No Abstract] [Full Text] [Related]
2. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
[TBL] [Abstract][Full Text] [Related]
3. Acceptability, adherence, and clinical outcomes, of amoxicillin dispersible tablets versus oral suspension in treatment of children aged 2-59 Months with pneumonia, Kenya: A cluster randomized controlled trial.
Angwa LM; Ouma C; Okoth P; Nyamai R; Kamau NG; Mutai K; Onono MA
Heliyon; 2020 Apr; 6(4):e03786. PubMed ID: 32322742
[TBL] [Abstract][Full Text] [Related]
4. Optimising adherence to childhood pneumonia treatment: the design and development of patient instructions and a job aid for amoxicillin dispersible tablets.
Ebels K; Faulx D; Gerth-Guyette E; Murunga P; Mahapatro S; Das MK; Ginsburg AS
Arch Dis Child; 2016 Jan; 101(1):57-62. PubMed ID: 26489802
[TBL] [Abstract][Full Text] [Related]
5. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
[TBL] [Abstract][Full Text] [Related]
6. Understanding key drivers and barriers to implementation of the WHO recommendations for the case management of childhood pneumonia and possible serious bacterial infection with amoxicillin dispersible tablets (DT) in Bangladesh: a qualitative study.
Rahman M; Delarosa J; Luies SK; Alom KR; Quintanar-Solares M; Jabeen I; Ahmed T; Abu-Haydar E; Sarma H
BMC Health Serv Res; 2020 Feb; 20(1):142. PubMed ID: 32093696
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the use of job aids and user instructions to improve adherence for the treatment of childhood pneumonia using amoxicillin dispersible tablets in a low-income setting: a mixed-method study.
Sarma H; Gerth-Guyette E; Shakil SA; Alom KR; Abu-Haydar E; D'Rozario M; Tariqujjaman M; Arifeen SE; Ahmed T
BMJ Open; 2019 May; 9(5):e024978. PubMed ID: 31152030
[TBL] [Abstract][Full Text] [Related]
8. Comparison of methods to assess adherence to small-quantity lipid-based nutrient supplements (SQ-LNS) and dispersible tablets among young Burkinabé children participating in a community-based intervention trial.
Abbeddou S; Hess SY; Yakes Jimenez E; Somé JW; Vosti SA; Guissou RM; Ouédraogo JB; Brown KH
Matern Child Nutr; 2015 Dec; 11 Suppl 4(Suppl 4):90-104. PubMed ID: 25521188
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi.
Nkwopara E; Schmicker R; Mvalo T; Phiri M; Phiri A; Couasnon M; McCollum ED; Ginsburg AS
BMJ Open Respir Res; 2019; 6(1):e000415. PubMed ID: 31548894
[TBL] [Abstract][Full Text] [Related]
12. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
Atkinson M; Lakhanpaul M; Smyth A; Vyas H; Weston V; Sithole J; Owen V; Halliday K; Sammons H; Crane J; Guntupalli N; Walton L; Ninan T; Morjaria A; Stephenson T
Thorax; 2007 Dec; 62(12):1102-6. PubMed ID: 17567657
[TBL] [Abstract][Full Text] [Related]
14. Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia.
Benninger MS
Expert Opin Pharmacother; 2003 Oct; 4(10):1839-46. PubMed ID: 14521493
[TBL] [Abstract][Full Text] [Related]
15. Rational use of antibiotics by community health workers and caregivers for children with suspected pneumonia in Zambia: a cross-sectional mixed methods study.
Graham K; Sinyangwe C; Nicholas S; King R; Mukupa S; Källander K; Counihan H; Montague M; Tibenderana J; Hamade P
BMC Public Health; 2016 Aug; 16(1):897. PubMed ID: 27567604
[TBL] [Abstract][Full Text] [Related]
16. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
Lorgelly PK; Atkinson M; Lakhanpaul M; Smyth AR; Vyas H; Weston V; Stephenson T
Eur Respir J; 2010 Apr; 35(4):858-64. PubMed ID: 19717479
[TBL] [Abstract][Full Text] [Related]
17. Non-adherence to oral antibiotics for community paediatric pneumonia treatment in Malawi - A qualitative investigation.
King C; Nightingale R; Phiri T; Zadutsa B; Kainja E; Makwenda C; Colbourn T; Stevenson F
PLoS One; 2018; 13(10):e0206404. PubMed ID: 30379968
[TBL] [Abstract][Full Text] [Related]
18. Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Phiri M; Schmicker R; Hwang J; Ndamala CB; Phiri A; Lufesi N; May S
N Engl J Med; 2020 Jul; 383(1):13-23. PubMed ID: 32609979
[TBL] [Abstract][Full Text] [Related]
19. Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey.
Nsabagasani X; Ogwal-Okeng J; Mbonye A; Ssengooba F; Muhumuza S; Hansen EH
J Pharm Policy Pract; 2015; 8(1):18. PubMed ID: 25995847
[TBL] [Abstract][Full Text] [Related]
20. Non-adherence to community oral-antibiotic treatment in children with fast-breathing pneumonia in Malawi- secondary analysis of a prospective cohort study.
Nightingale R; Colbourn T; Mukanga D; Mankhambo L; Lufesi N; McCollum ED; King C
Pneumonia (Nathan); 2016; 8():21. PubMed ID: 28702300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
